Freeline Therapeutics (FRLN) Q2 2023 Earnings

Aug 15Confirmed
Aug 2022
Nov 2022
Q4 2022
Q2 2023
-0.51
-0.34
-0.17
0

Details

Expected EPS
N/A
Actual EPS
-0.23
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Freeline Therapeutics⁩ (⁦FRLN⁩) has reported earnings of ⁦-0.23⁩ per share for ⁦Q2 2023⁩.

0 Comments

Share your thoughts